Chronic mild stress-induced depression-like symptoms in rats and abnormalities in catecholamine uptake in small arteries

Psychosomatic Medicine

Volumn 74, Issue 3, 2012, Pages 278-287

  Bouzinova, Elena V ^a   Møller Nielsen, Nina ^b   Boedtkjer, Donna B ^b   Broegger, Torbjoern ^b   Wiborg, Ove ^a   Aalkjaer, Christian ^b   Matchkov, Vladimir V ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

anhedonia and resilience; blood pressure; cardiovascular disorders; catecholamine uptake; resistance arteries

Indexed keywords

COCAINE; CORTICOSTERONE; NORADRENALIN; NORADRENALIN TRANSPORTER;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY; ARTERY WALL; ARTICLE; BLOOD VESSEL INNERVATION; CARDIOVASCULAR FUNCTION; CATECHOLAMINE UPTAKE; CHRONIC STRESS; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; EXPERIMENTAL RAT; IN VITRO STUDY; MALE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; SUGAR INTAKE; SYMPATHETIC INNERVATION;

EID: 84859710374     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31824c40a9     Document Type: Article

References (63)

1. Plante GE. Vascular response to stress in health and disease. Metabolism 2002;51(6 suppl 1):25-30. (Pubitemid 34624857)
2. Dawood T, Schlaich M, Brown A, Lambert G. Depression and blood pressure control: all antidepressants are not the same. Hypertension 2009;54:e1.
3. Scherrer JF, Xian H, Bucholz KK, Eisen SA, Lyons MJ, Goldberg J, Tsuang M, True WR. A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med 2003;65:548-57. (Pubitemid 36900249)
4. Rutledge T, Hogan BE. A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med 2002;64:758-66.
5. Salomon K, Clift A, Karlsdottir M, Rottenberg J. Major depressive disorder is associated with attenuated cardiovascular reactivity and impaired recovery among those free of cardiovascular disease. Health Psychol 2009;28:157-65.
6. Licht CM, de Geus EJ, Seldenrijk A, van Hout HP, Zitman FG, van DR, Penninx BW. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 2009;53:631-8.
7. Delaney JA, Oddson BE, Kramer H, Shea S, Psaty BM, McClelland RL. Baseline depressive symptoms are not associated with clinically important levels of incident hypertension during two years of follow-up: the Multi-Ethnic Study of Atherosclerosis. Hypertension 2010;55:408-14.
8. Brock JA, Yeoh M, McLachlan EM. Enhanced neurally evoked responses and inhibition of norepinephrine reuptake in rat mesenteric arteries after spinal transection. Am J Physiol Heart Circ Physiol 2006;290:H398-405.
9. Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, Socratous F, Kaye DM, Schlaich MP, Hickie I, Lambert GW. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens 2007;25:2117-24. (Pubitemid 47476310)
10. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 2001;91:35-62. (Pubitemid 33055773)
11. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990;70:921-61. (Pubitemid 20364819)
12. Eller NH, Netterstrom B, Allerup P. Progression in intima media thickness - the significance of hormonal biomarkers of chronic stress. Psychoneuroendocrinology 2005;30:715-23. (Pubitemid 40775739)
13. Grippo AJ. Mechanisms underlying altered mood and cardiovascular dysfunction: the value of neurobiological and behavioral research with animal models. Neurosci Biobehav Rev 2009;33:171-80.
14. Bergstrom A, Jayatissa MN, Thykjaer T, Wiborg O. Molecular pathways associated with stress resilience and drug resistance in the chronic mild stress rat model of depression: a gene expression study. J Mol Neurosci 2007;33:201-15. (Pubitemid 47574943)
15. Bergstrom A, Jayatissa MN, Mork A, Wiborg O. Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study. Brain Res 2008;1196:41-52.
16. Jayatissa MN, Bisgaard C, Tingstrom A, Papp M, Wiborg O. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 2006;31:2395-404. (Pubitemid 44607057)
17. Grippo AJ, Moffitt JA, Johnson AK. Evaluation of baroreceptor reflex function in the chronic mild stress rodent model of depression. Psychosom Med 2008;70:435-43.
18. Grippo AJ, Beltz TG, Weiss RM, Johnson AK. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biol Psychiatry 2006;59:309-16. (Pubitemid 43238355)
19. Grippo AJ, Francis J, Beltz TG, Felder RB, Johnson AK. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav 2005;84:697-706. (Pubitemid 40693431)
20. Katz RJ. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol Biochem Behav 1982;16:965-8. (Pubitemid 12081655)
21. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005;52:90-110. (Pubitemid 41160326)
22. Grippo AJ, Moffitt JA, Johnson AK. Cardiovascular alterations and autonomic imbalance in an experimental model of depression. Am J Physiol Regul Integr Comp Physiol 2002;282:R1333-41. (Pubitemid 34664517)
23. Christiansen S, Bouzinova E, Palme R, Wiborg O. Circadian activity of the hypothalamic pituitary adrenal axis is differentially affected in the rat chronic mild stress model of depression. Stress 2012 Feb 23. [Epub ahead of print].
24. Henningsen K, Andreasen JT, Bouzinova EV, Jayatissa MN, Jensen MS, Redrobe JP, Wiborg O. Cognitive deficits in the rat chronic mild stress model for depression: relation to anhedonic-like responses. Behav Brain Res 2009;198:136-41.
25. Garcia LS, Comim CM, Valvassori SS, Reus GZ, Stertz L, Kapczinski F, Gavioli EC, Quevedo J. Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:450-5.
26. Grippo AJ, Beltz TG, Johnson AK. Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol Behav 2003;78:703-10. (Pubitemid 36628099)
27. Palacios R, Campo A, Henningsen K, Verhoye M, Poot D, Dijkstra J, Van AJ, Benveniste H, Sijbers J, Wiborg O, Van der Linden A. Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model. Biol Psychiatry 2011;70:449-57.
28. Christensen T, Bisgaard CF, Wiborg O. Biomarkers of anhedonic-like behavior, antidepressant drug refraction, and stress resilience in a rat model of depression. Neuroscience 2011;196:66-79.
29. Jayatissa MN, Bisgaard CF, West MJ, Wiborg O. The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology 2008;54:530-41.
30. Holm MM, Nieto-Gonzalez JL, Vardya I, Henningsen K, Jayatissa MN, Wiborg O, Jensen K. Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression. Hippocampus 2011;21:422-33.
31. Asnis GM, Halbreich U, Ryan ND, Rabinowicz H, Puig-Antich J, Nelson B, Novacenko H, Friedman JH. The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression. Psychoneuroendocrinology 1987;12:295-301. (Pubitemid 17138227)
32. Isingrini E, Surget A, Belzung C, Freslon JL, Frisbee J, O'Donnell J, Camus V, d'Audiffret A. Altered aortic vascular reactivity in the unpredictable chronic mild stress model of depression in mice: UCMS causes relaxation impairment to ACh. Physiol Behav 2011;103:540-6.
33. Isingrini E, Belzung C, d'Audiffret A, Camus V. Early and late-onset effect of chronic stress on vascular function in mice: a possible model of the impact of depression on vascular disease in aging. Am J Geriatr Psychiatry 2011;19:335-46.
34. d'Audiffret AC, Frisbee SJ, Stapleton PA, Goodwill AG, Isingrini E, Frisbee JC. Depressive behavior and vascular dysfunction: a link between clinical depression and vascular disease? J Appl Physiol 2010;108:1041-51.
35. 2+ sensitivity, and hypertension development in mice. Circulation 2011;124:1819-29.
36. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation - contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987;61:181-6. (Pubitemid 17137117)
37. Mulvany MJ, Aalkjaer C, Christensen J. Changes in noradrenaline sensitivity and morphology of arterial resistance vessels during development of high blood pressure in spontaneously hypertensive rats. Hypertension 1980;2:664-71. (Pubitemid 11208299)
38. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19-26. (Pubitemid 8132079)
39. Broegger T, Jacobsen JC, Secher Dam V, Boedtkjer DM, Kold-Petersen H, Pedersen FS, Aalkjaer C, Matchkov VV. Bestrophin is important for the rhythmic but not the tonic contraction in rat mesenteric small arteries. Cardiovasc Res 2011;91:685-93.
40. Grippo AJ, Johnson AK. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009;12:1-21.
41. Tafet GE, Bernardini R. Psychoneuroendocrinological links between chronic stress and depression. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:893-903. (Pubitemid 37141377)
42. Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet 2007;370:1089-100. (Pubitemid 47419001)
43. Carter CS, Grippo AJ, Pournajafi-Nazarloo H, Ruscio MG, Porges SW. Oxytocin, vasopressin and sociality. Prog Brain Res 2008;170:331-6. (Pubitemid 352010239)
44. Lambert E, Dawood T, Straznicky N, Sari C, Schlaich M, Esler M, Lambert G. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens 2010;28:543-50.
45. Jayatissa MN, Henningsen K, Nikolajsen G, West MJ, Wiborg O. A reduced number of hippocampal granule cells does not associate with an anhedonia-like phenotype in a rat chronic mild stress model of depression. Stress 2010;13:95-105.
46. Bisgaard CF, Jayatissa MN, Enghild JJ, Sanchez C, Artemychyn R, Wiborg O. Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression. J Mol Neurosci 2007;32:132-44. (Pubitemid 47460449)
47. Blakely RD, De Felice LJ, Hartzell HC. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 1994;196:263-81.
48. Horvath G, Lieb T, Conner GE, Salathe M, Wanner A. Steroid sensitivity of norepinephrine uptake by human bronchial arterial and rabbit aortic smooth muscle cells. Am J Respir Cell Mol Biol 2001;25:500-6. (Pubitemid 33037683)
49. Horvath G, Sutto Z, Torbati A, Conner GE, Salathe M, Wanner A. Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003;285:L829-37. (Pubitemid 37158829)
50. Martel F, Azevedo I. An update on the extraneuronal monoamine transporter (EMT): characteristics, distribution and regulation. Curr Drug Metab 2003;4:313-8. (Pubitemid 36958331)
51. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 2004;43:169-75. (Pubitemid 38174169)
52. Kreulen DL. Properties of the venous and arterial innervation in the mesentery. J Smooth Muscle Res 2003;39:269-79. (Pubitemid 38404999)
53. Parrish DC, Gritman K, Van Winkle DM, Woodward WR, Bader M, Habecker BA. Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter. Am J Physiol Heart Circ Physiol 2008;294:H99-106.
54. Li W, Knowlton D, Woodward WR, Habecker BA. Regulation of noradrenergic function by inflammatory cytokines and depolarization. J Neurochem 2003;86:774-83. (Pubitemid 36897456)
55. Luo M, Hess MC, Fink GD, Olson LK, Rogers J, Kreulen DL, Dai X, Galligan JJ. Differential alterations in sympathetic neurotransmission in mesenteric arteries and veins in DOCA-salt hypertensive rats. Auton Neurosci 2003;104:47-57. (Pubitemid 36143809)
56. Rusnak M, Kvetnansky R, Jelokova J, Palkovits M. Effect of novel stressors on gene expression of tyrosine hydroxylase and monoamine transporters in brainstem noradrenergic neurons of long-term repeatedly immobilized rats. Brain Res 2001;899:20-35. (Pubitemid 32324144)
57. Haenisch B, Bilkei-Gorzo A, Caron MG, Bonisch H. Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression. J Neurochem 2009;111:403-16.
58. Haller J, Bakos N, Rodriguiz RM, Caron MG, Wetsel WC, Liposits Z. Behavioral responses to social stress in noradrenaline transporter knockout mice: effects on social behavior and depression. Brain Res Bull 2002;58:279-84. (Pubitemid 34786459)
59. Haenisch B, Bonisch H. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. Pharmacol Ther 2011;129:352-68.
60. Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S, Petre CO. Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1214-24. (Pubitemid 41674636)
61. Sun Z, Fan Y, Zha Q, Zhu MY. Corticosterone up-regulates expression and function of norepinephrine transporter in SK-N-BE(2)C cells. J Neurochem 2010;113:105-16.
62. Hayer-Zillgen M, Bruss M, Bonisch H. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 2002;136:829-36. (Pubitemid 34836857)
63. Horvath G, Wanner A. Molecular targets for steroids in airway vascular smooth muscle. Arch Physiol Biochem 2003;111:341-4. (Pubitemid 40292075)